En Es
Categories

Industry News

Global Surgical Imaging Market to Reach USD 1.63 Billion by 2022

By Medimaging International staff writers
28 Nov 2017

Image: The global surgical imaging market is projected to grow to USD 1.63 billion by 2022 (Photo courtesy of GE Healthcare).The global surgical imaging market is projected to grow at a CAGR of 5.5% from an estimated value of USD 1.25 billion in 2017 to USD 1.63 billion by 2022, driven mainly by the growing popularity of Flat Panel Detector C-arms (FPD C-arms) owing to the advantages of FPDs over image intensifiers, reimbursement cuts on analog radiography systems, and rising demand for minimally invasive procedures.

These are the latest findings of MarketsandMarkets (Northbrook, IL, USA), a global market research company.

Based on application, the orthopedic and trauma surgeries segment is expected to command the largest share of the surgical imaging market in 2017, due to the increasing popularity of minimally invasive procedures in orthopedic and trauma surgeries and the advantage of 3D navigation with the use of C-arms.

North America is expected to account for the largest share of the global surgical imaging market in 2017, followed by Europe, Asia Pacific, and the Rest of the World. The large share of the North American region can be attributed to an increasing number of overuse sports injuries, rising prevalence of Cardiovascular Diseases (CVDs), increasing cases of cardiac arrest, and growing number of minimally invasive procedures performed in Canada. However, Asia Pacific is expected to register the highest CAGR of 7.1% during the forecast period, driven by the rapid growth in Japan’s geriatric population, China’s increasing healthcare reforms, India’s improving healthcare infrastructure, and the rising number of orthopedic and CVD procedures in Australia.

Related Links:
MarketsandMarkets



E-mail Print
FaceBook Twitter Google+ Linked in

GE Healthcare

GE Healthcare provides medical imaging and information technologies, medical diagnostics, patient monitoring systems, drug discovery, biopharmaceutical manufacturing technologies, performance improvement and performance solutions services. The company’s product areas include anesthesia delivery, diagnostic ECG, mammography, radiography, surgical imaging, maternal-infant care and clinical consumables.
More info

More articles about GE Healthcare

30 Jan 2020
Study Finds Most Healthcare Institutions Plan to Use AI and Develop Own AI Algorithm
 A new study of healthcare professionals has revealed that Artificial Intelligence (AI) is widely expected to drive important benefits across the health system, from increasing efficiency to improving patient outcomes, but may also be the key to making healthcare more human. AI’s benefits range from increasing the amount of time clinicians can spend with patients and on cross-care team collaboration to enhancing the ability to deliver preventative care.
Read More
26 Sep 2019
GE Healthcare and Affibody Collaborate to Develop PET Imaging Tracers
GE Healthcare and Affibody AB have entered into a strategic collaboration to develop and commercialize Affibody-based PET imaging tracers, with initial focus on HER2 and PD-L1.
Read More
22 Aug 2019
GE Healthcare Partners with Fujitsu to Develop AI for Spotting Brain Aneurysms
GE Healthcare has entered into a research collaboration with Fujitsu Australia to diagnose and monitor brain aneurysms on scans faster and more efficiently by using artificial intelligence.
Read More
03 May 2019
First Deep Learning-Based Image Reconstruction Technology Receives FDA Clearance
GE Healthcare has received 510(k) clearance from the U.S. FDA for its Deep Learning Image Reconstruction (DLIR) engine on its new Revolution Apex CT device, and as an upgrade to its Revolution CT system in the U.S.
Read More
18 Oct 2018
GE Healthcare and ESR Enter AI Partnership for ECR 2019
GE Healthcare (Chicago, IL, USA) and the European Society of Radiology (Vienna, Austria) will be partnering on artificial intelligence (AI) for the upcoming European Congress of Radiology (ECR) to be held in Vienna, Austria on February 27-March 3, 2019. The partnership will include joint sessions on AI and a dedicated space at GE Healthcare’s booth where visitors will be able to experience the AI transformation through interactive tools.
Read More
15 Oct 2018
GE Healthcare to Implement First AI-Powered Hospital Command Centers
GE Healthcare is collaborating with hospital service providers in Europe and the US for implementing an artificial intelligence (AI)-powered command center to effectively and efficiently synchronize all elements of a patient's hospital experience. The AI-powered system will support caregivers to enhance patient safety, orchestrate seamless care delivery and get patients back home sooner.
Read More
26 Jun 2018
GE to Spin Off Healthcare Business
In line with a sweeping strategic reorganization, General Electric Company has announced the decision to spin off its Healthcare business segment as an independent company. The move comes on the heels of a lengthy managerial review conducted by GE management under newly appointed CEO John Flannery.
Read More
16 Jan 2018
GE Healthcare and Roche Partner to Develop Digital Diagnostics Platform
GE Healthcare and Roche have entered into a strategic, long-term partnership to jointly develop and co-market digital clinical decision support solutions. Initially, the partnership will focus on products that accelerate and improve individualized treatment options for cancer and critical care patients.
Read More

Additional news

17 Feb 2020
New System Combines Advanced Optical Imaging with AI Algorithm to Accurately Identify Brain Tumors
 Researchers from the NYU Grossman School of Medicine (New York, NY, USA) and the University of Michigan (Ann Arbor, MI, USA) have developed a novel method of combining advanced optical imaging with an artificial intelligence (AI) algorithm to produce accurate, real-time intraoperative diagnosis of brain tumors. The imaging technique, stimulated Raman histology (SRH), reveals tumor infiltration in human tissue by collecting scattered laser light, illuminating essential features not typically seen in standard histologic images. The microscopic images are then processed and analyzed with AI, allowing surgeons to see a predicted brain tumor diagnosis in less than three minutes. Using the same technology, after the resection, the surgeons can accurately detect and remove otherwise undetectable tumor.
Read More
10 Feb 2020
Global Medical Robotics Market to Reach USD 13.90 Billion by 2026
 The global medical robotics market is projected to grow at a double-digit CAGR from 2019 to 2026 to reach USD 13.90 billion by 2026, driven by the increasing demand for minimally invasive surgery, rising prevalence of gynecology, urology and orthopedic disorders, increasing aging population, technological innovations, growing adoption of medical robots among the population and increasing clinical trials.
Read More
04 Feb 2020
Patient Handling Equipment Market to Reach USD 12.6 Billion by 2024
 The global patient handling equipment market is projected to grow at a CAGR of 7.2% from USD 8.9 billion in 2019 to USD 12.6 billion by 2024, driven mainly by the rising geriatric population, high risk of injuries to caregivers during manual handling of patients, and regulations for ensuring the safety of healthcare personnel during manual lifting processes. However, continued difficulties in handling bariatric patients are expected to limit the market growth to some extent.
Read More
30 Jan 2020
Quest Diagnostics Acquires Blueprint Genetics
 Quest Diagnostics (Secaucus, NJ, USA), a provider of diagnostic information services, has acquired Blueprint Genetics (Helsinki, Finland), a specialty genetic testing company with expertise in gene variant interpretation based on next generation sequencing (NGS) and proprietary bioinformatics. Together, Quest and Blueprint Genetics will broaden access to actionable insights in genetic and rare diseases, improving patient care and pharmaceutical drug research and development.
Read More
27 Jan 2020
JNJ Acquires Remaining Stake in Verb Surgical
 Johnson & Johnson (New Brunswick, N.J., USA) has acquired the remaining stake in Verb Surgical Inc. (Santa Clara, CA, USA), following a successful strategic collaboration with Verily, an Alphabet company. Verb Surgical's robotics and data science capabilities, combined with Johnson & Johnson's health care leadership and global reach, aim to make medical interventions smarter, less invasive and more personalized.
Read More
22 Jan 2020
Global Point of Care Testing (POCT) Market to Reach USD 46.7 Billion by 2024
 The global point of care testing (POCT) market is expected to surpass USD 37 billion by 2025, driven mainly by the migration of POCT from the hospital environment to a range of medical environments, including the workplace, home, disaster care and most recently, convenience clinics. POCT now appears to be headed for a bigger role in diagnosis and monitoring patient care. Additionally, growing awareness about early disease diagnosis and prevention has stimulated the demand for POCT for detecting cancer and infectious disease in the early stages. Moreover, the rising incidence of infectious diseases and chronic conditions, such as cardiovascular diseases and diabetes in the developing countries such as India and China, is stimulating the demand for POCT services.
Read More
16 Jan 2020
Radiomic Algorithm Predicts if Patient’s Cancer Can Return 10 Years After Treatment
 A new study by researchers at Penn Medicine (Philadelphia, PA, USA) has found that Magnetic Resonance Imaging (MRI) and an emerging field of medicine called radiomics — which uses algorithms to extract a large amount of features from medical images — could help to characterize the heterogeneity of cancer cells within a tumor and allow for a better understanding of the causes and progression of a person’s individual disease.
Read More
13 Jan 2020
PENTAX Medical Clears CE Mark for New AI-Assisted Polyp Detector
 PENTAX Medical (Tokyo, Japan) has cleared CE mark for DISCOVERY, its Artificial Intelligence (AI) assisted polyp detector designed to support endoscopists in finding potential polyps during a colorectal examination.
Read More
07 Jan 2020
New AI Model Identifies Women Facing Future Risk of Breast Cancer
 Researchers from the Karolinska Institute (Stockholm, Sweden) have developed a sophisticated type of artificial intelligence (AI) which can outperform existing models at predicting which women are at future risk of breast cancer.
Read More
Copyright © 2000-2020 TradeMed.com. All rights reserved. | Terms And Conditions